Company / Shares Outstanding
Zenas BioPharma, Inc. Shares Outstanding History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
41.8M
FY2025
5-year range
1.5M / 41.8M
FY2023-FY2025
Trend
+2550.4%
vs FY2024
Sector context
#181 of 212
Health Care
What the data says
Shares Outstanding changed +2550% YoY in FY2025, a notable deviation from the 2-year average annual change of +1277%.
Based on SEC 10-K filings.
41793412.00 in FY2025.
Increased from 1531178.00 to 41793412.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 212This company 41.8M Sector average 306.7M
▼
-86.4% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 2550.4% year-over-year.
- Ranks #181 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 41.8M | +2550.4% |
| FY2024 | 1.6M | +3.0% |
| FY2023 | 1.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026